These injections are intramuscular, so wear loose clothing that allows us to access your upper arms on treatment day
AOD-9604 is more focused on fat metabolism, offering a more tailored profile
Stay hydrated between meals, not during them
BPC-157 is not FDA-approved for treating back pain or spinal conditions
Vita Pure offers personalized Semaglutide treatments in Richmond, Virginia, to help you achieve your health and wellness goals
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al